Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates.

The incidence of human Campylobacter jejuni and C. coli infections has increased markedly in many parts of the world in the last decade as has the number of quinolone-resistant and, to a lesser extent, macrolide-resistant Campylobacter strains causing infections. We review macrolide and quinolone re...

Descripción completa

Detalles Bibliográficos
Autores principales: Engberg, J, Aarestrup, F M, Taylor, D E, Gerner-Smidt, P, Nachamkin, I
Formato: Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2001
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2631682/
https://www.ncbi.nlm.nih.gov/pubmed/11266291
_version_ 1782163960600985600
author Engberg, J
Aarestrup, F M
Taylor, D E
Gerner-Smidt, P
Nachamkin, I
author_facet Engberg, J
Aarestrup, F M
Taylor, D E
Gerner-Smidt, P
Nachamkin, I
author_sort Engberg, J
collection PubMed
description The incidence of human Campylobacter jejuni and C. coli infections has increased markedly in many parts of the world in the last decade as has the number of quinolone-resistant and, to a lesser extent, macrolide-resistant Campylobacter strains causing infections. We review macrolide and quinolone resistance in Campylobacter and track resistance trends in human clinical isolates in relation to use of these agents in food animals. Susceptibility data suggest that erythromycin and other macrolides should remain the drugs of choice in most regions, with systematic surveillance and control measures maintained, but fluoroquinolones may now be of limited use in the empiric treatment of Campylobacter infections in many regions.
format Text
id pubmed-2631682
institution National Center for Biotechnology Information
language English
publishDate 2001
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-26316822009-05-20 Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates. Engberg, J Aarestrup, F M Taylor, D E Gerner-Smidt, P Nachamkin, I Emerg Infect Dis Research Article The incidence of human Campylobacter jejuni and C. coli infections has increased markedly in many parts of the world in the last decade as has the number of quinolone-resistant and, to a lesser extent, macrolide-resistant Campylobacter strains causing infections. We review macrolide and quinolone resistance in Campylobacter and track resistance trends in human clinical isolates in relation to use of these agents in food animals. Susceptibility data suggest that erythromycin and other macrolides should remain the drugs of choice in most regions, with systematic surveillance and control measures maintained, but fluoroquinolones may now be of limited use in the empiric treatment of Campylobacter infections in many regions. Centers for Disease Control and Prevention 2001 /pmc/articles/PMC2631682/ /pubmed/11266291 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research Article
Engberg, J
Aarestrup, F M
Taylor, D E
Gerner-Smidt, P
Nachamkin, I
Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates.
title Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates.
title_full Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates.
title_fullStr Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates.
title_full_unstemmed Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates.
title_short Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates.
title_sort quinolone and macrolide resistance in campylobacter jejuni and c. coli: resistance mechanisms and trends in human isolates.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2631682/
https://www.ncbi.nlm.nih.gov/pubmed/11266291
work_keys_str_mv AT engbergj quinoloneandmacrolideresistanceincampylobacterjejuniandccoliresistancemechanismsandtrendsinhumanisolates
AT aarestrupfm quinoloneandmacrolideresistanceincampylobacterjejuniandccoliresistancemechanismsandtrendsinhumanisolates
AT taylorde quinoloneandmacrolideresistanceincampylobacterjejuniandccoliresistancemechanismsandtrendsinhumanisolates
AT gernersmidtp quinoloneandmacrolideresistanceincampylobacterjejuniandccoliresistancemechanismsandtrendsinhumanisolates
AT nachamkini quinoloneandmacrolideresistanceincampylobacterjejuniandccoliresistancemechanismsandtrendsinhumanisolates

Ejemplares similares